These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5714957)

  • 21. Studies on the persistence of malarial antibody response.
    Collins WE; Skinner JC; Jeffery GM
    Am J Epidemiol; 1968 May; 87(3):592-8. PubMed ID: 4871675
    [No Abstract]   [Full Text] [Related]  

  • 22. Interferon-gamma induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine.
    Kremsner PG; Neifer S; Chaves MF; Rudolph R; Bienzle U
    Eur J Immunol; 1992 Nov; 22(11):2873-8. PubMed ID: 1425913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malaria immunity and premunition in a Plasmodium berghei mouse model.
    Eling WM
    Isr J Med Sci; 1978 May; 14(5):542-53. PubMed ID: 355189
    [No Abstract]   [Full Text] [Related]  

  • 24. Antimalarial activity of a riboflavin analog against Plasmodium vinckei in vivo and Plasmodium falciparum in vitro.
    Cowden WB; Butcher GA; Hunt NH; Clark IA; Yoneda F
    Am J Trop Med Hyg; 1987 Nov; 37(3):495-500. PubMed ID: 3688306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunomodulating effect of a new polyamine (the MAP-1987) administered with chloroquine in plasmodia infected mice.
    Földes J; Matyi A
    Acta Microbiol Immunol Hung; 1994; 41(1):73-82. PubMed ID: 7921853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chloroquine-resistant malaria.
    Wellems TE; Plowe CV
    J Infect Dis; 2001 Sep; 184(6):770-6. PubMed ID: 11517439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative studies on the immunogenicity of infective and attenuated sporozoites of Plasmodium berghei.
    Orjih AU; Cochrane AH; Nussenzweig RS
    Trans R Soc Trop Med Hyg; 1982; 76(1):57-61. PubMed ID: 7043807
    [No Abstract]   [Full Text] [Related]  

  • 28. [New 6-aminoquinolines with antimalarial activity. Test results on schizontocidal and causalprophylactic effects in rodent- and avian malaria (Plasmodium vinckei, P. berghei and P. cathemerium)].
    Fink E; Nickel P; Dann O
    Arzneimittelforschung; 1970 Nov; 20(11):1775-7. PubMed ID: 5536991
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunological studies with simian malarias. I. Antigenic variants of Plasmodium cynomolgi bastianellii.
    Voller A; Rossan RN
    Trans R Soc Trop Med Hyg; 1969; 63(1):46-56. PubMed ID: 4978046
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum antibody in acquired malarial immunity.
    Cohen S; Butcher GA
    Trans R Soc Trop Med Hyg; 1971; 65(2):125-35. PubMed ID: 4934028
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasmodium yoelii nigeriensis: biological mechanisms of resistance to chloroquine.
    Beauté-Lafitte A; Altemayer-Caillard V; Chabaud AG; Landau I
    Parasite; 1994 Sep; 1(3):227-33. PubMed ID: 9140489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sporozoite-induced immunity in mammalian malaria. A review.
    Nussenzweig RS; Vanderberg J; Spitalny GL; Rivera CI; Orton C; Most H
    Am J Trop Med Hyg; 1972 Sep; 21(5):722-8. PubMed ID: 4561520
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasmodium chloroquine resistance and the search for a replacement antimalarial drug.
    Wellems TE
    Science; 2002 Oct; 298(5591):124-6. PubMed ID: 12364789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malaria. Chloroquine makes a comeback.
    Vogel G
    Science; 2006 Nov; 314(5801):904. PubMed ID: 17095662
    [No Abstract]   [Full Text] [Related]  

  • 35. Active immunization of mice against Plasmodium berghei. Cross-resistance to a recently isolated strain.
    Weiss ML
    Am J Trop Med Hyg; 1968 Jul; 17(4):516-21. PubMed ID: 5672782
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of free radicals and antioxidative enzymes in erythrocytes and liver cells in the course of Plasmodium berghei and Plasmodium vinckei infection of mice.
    Földes J; Matyi A; Matkovics B
    Acta Microbiol Immunol Hung; 1994; 41(2):153-61. PubMed ID: 7804719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmodium fragile and Macaca mulatta monkeys as a model system for the study of malaria vaccines.
    Collins WE; Chin W; Skinner JC
    Am J Trop Med Hyg; 1979 Nov; 28(6):948-54. PubMed ID: 116557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Development of chloroquine resistance in an urban area. Results of surveys in Dakar and Pikine].
    Gaye O; Faye O; Bah IB; Diallo S; Diouf M; Ndiaye P; Ndiaye AA; Trape JF
    Ann Soc Belg Med Trop; 1991 Dec; 71(4):329-30. PubMed ID: 1789708
    [No Abstract]   [Full Text] [Related]  

  • 39. [Relapses and indirect fluorescent antibody level in vivax malaria patients after chloroquine and chloroquine-primaquine treatment].
    Wang K; Liu YL; Zhang PN; Liu JX
    Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1984; 2(4):224-7. PubMed ID: 6394170
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasmodium chabaudi chabaudi: effect of low parasitemias on immunity in CB6F1 mice.
    Favila-Castillo L; Monroy-Ostria A; Garcia-Tapia D
    Exp Parasitol; 1999 May; 92(1):73-80. PubMed ID: 10329368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.